Compare Johnson & Johnson (JNJ) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs US Bancorp — how do they compare? Johnson & Johnson trades at $251.13 (market cap $598.96B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: Johnson & Johnson is far larger — about 6.1× US Bancorp's market cap, and US Bancorp pays the higher dividend (3.29%). Which is the better fit depends on your goals.
| JNJ | USB | |
|---|---|---|
Market Cap | $598.96B | $98.36B |
Volume | 6,156,228 | — |
Sector | Health | Financials |
52-Week High | $267.24 | $64.01 |
52-Week Low | $164.36 | $43.94 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
